Study of salivary arecoline in areca nut chewers
- PMID: 30651702
- PMCID: PMC6306580
- DOI: 10.4103/jomfp.JOMFP_143_18
Study of salivary arecoline in areca nut chewers
Abstract
Aims: Arecoline, a predominant alkaloid present in arecanut, has been implicated in the pathogenesis of several oral diseases because of its mutagenic and carcinogenic potential. The response of cultured cells to arecoline is highly dependent on its concentration; arecoline stimulates cultured cells above 0.1 μg/ml and is cytotoxic above 10 μg/ ml. Although this alkaloid seems important for areca nut induced oral diseases and carcinogenesis, little is known of the levels achieved before, during and after chewing. Also, it is prudent to understand its effects in arecanut chewers for a comprehensive understanding of its pathogenesis. Accordingly, the present study quantified the salivary arecoline levels in arecanut chewers.
Materials and methods: The study participants were divided into Study Group A & B and Control Group C; unstimulated whole saliva was collected by spitting method for a period of 5 min. Then, participants in Group A and C chewed 0.5 g of areca nut without any other additives while in Group B were asked to chew 0.5 g of inert rubber base impression material. Stimulated whole saliva from all three groups was collected into graduated tubes during chewing at time intervals of 1, 3, 5, 10, 15, 20 and 25 min. Then, all participants were asked to remove nut particles or inert rubber base material from the mouth, and saliva samples were collected further up to 20 min, changing tubes at 5 min interval. Salivary arecoline was quantitated by HPLC-MS. The tabulation and descriptive statistics of the study were carried out.
Results: In the present study, baseline levels of arecoline were zero in all three groups, whereas mean salivary arecoline levels during chewing were 76.93 ng/ml, 129.83 ng/ml and 64.83 ng/ml and after chewing were 196.17 ng/ml, 321.12 ng/ml and 43.75 ng/ml in Groups A, B and Control respectively, which were significantly higher than reported threshold levels.
Conclusions: The data from this study reveals that a significant amount of arecoline would be trapped in oral cavity, or being re-circulated between blood and saliva might have resulted in surprisingly high levels of arecoline even 10 mins after chewing in both groups after which the levels started declining. The higher levels of salivary arecoline achieved during and after chewing are enough to cause cytotoxic and genotoxic effects on oral tissues over a period of time in chronic chewers. The great differences in salivary arecoline levels achieved during chewing, may contribute to the variable response to areca nut seen in communities where this habit is widespread. Areca nut users have persistent background salivary arecoline levels long after chewing, whereas concentrations achieved are highly variable and consistent with a role in oral pre-malignancy and malignancy..
Keywords: Arecanut; HPLC-MS; OSCC; OSMF; SALIVA; arecoline.
Conflict of interest statement
There are no conflicts of interest.
Figures
Similar articles
-
Salivary arecoline levels during areca nut chewing in human volunteers.J Oral Pathol Med. 2010 Jul;39(6):465-9. doi: 10.1111/j.1600-0714.2009.00881.x. Epub 2010 Apr 13. J Oral Pathol Med. 2010. PMID: 20412403
-
Quantification of Salivary Arecoline, Arecaidine and N-Methylnipecotic Acid Levels in Volunteers by Liquid Chromatography-Tandem Mass Spectrometry.J Anal Toxicol. 2015 Nov-Dec;39(9):714-9. doi: 10.1093/jat/bkv077. Epub 2015 Jul 30. J Anal Toxicol. 2015. PMID: 26232451
-
Pilot study of the pharmacokinetics of betel nut and betel quid biomarkers in saliva, urine, and hair of betel consumers.Drug Test Anal. 2016 Oct;8(10):1095-1099. doi: 10.1002/dta.1912. Epub 2015 Dec 1. Drug Test Anal. 2016. PMID: 26619803 Free PMC article.
-
Areca nut: a review.Arzneimittelforschung. 1976;26(5):951-6. Arzneimittelforschung. 1976. PMID: 786304 Review.
-
Potential Role of Host Microbiome in Areca Nut-Associated Carcinogenesis and Addiction.Molecules. 2022 Nov 24;27(23):8171. doi: 10.3390/molecules27238171. Molecules. 2022. PMID: 36500264 Free PMC article. Review.
Cited by
-
Systematic Review of Roles of Arecoline and Arecoline N-Oxide in Oral Cancer and Strategies to Block Carcinogenesis.Cells. 2023 Apr 21;12(8):1208. doi: 10.3390/cells12081208. Cells. 2023. PMID: 37190117 Free PMC article.
-
Areca catechu L. and Anredera cordifolia (Ten) Steenis supplementation reduces faecal parasites and improves caecal histopathology in laying hens.Int J Vet Sci Med. 2022 Jul 7;10(1):52-63. doi: 10.1080/23144599.2022.2090732. eCollection 2022. Int J Vet Sci Med. 2022. PMID: 35874604 Free PMC article.
-
Molecular mechanisms of arecoline-induced oral cancer: a network toxicology and molecular docking techniques integrated analysis.Discov Oncol. 2025 May 21;16(1):842. doi: 10.1007/s12672-025-02659-0. Discov Oncol. 2025. PMID: 40397259 Free PMC article.
-
Egr-1 mediates low-dose arecoline induced human oral mucosa fibroblast proliferation via transactivation of Wnt5a expression.BMC Mol Cell Biol. 2020 Nov 10;21(1):80. doi: 10.1186/s12860-020-00325-7. BMC Mol Cell Biol. 2020. PMID: 33167868 Free PMC article.
-
Salivary Profile Analysis Based on Oral Cancer Risk Habits: An Observational Cross-Sectional Study.Biomedicines. 2024 Aug 2;12(8):1748. doi: 10.3390/biomedicines12081748. Biomedicines. 2024. PMID: 39200213 Free PMC article.
References
-
- Secretan B, Straif K, Baan R, Grosse Y, El Ghissassi F, Bouvard V, et al. Areview of human carcinogens – Part E: Tobacco, areca nut, alcohol, coal smoke, and salted fish. Lancet Oncol. 2009;10:1033–4. - PubMed
-
- Warnakulasuriya S, Peters TJ. Introduction: Biology, medical and Socio-economic aspects of arecanut use. Addict Biol. 2002;7:75–6. - PubMed
-
- Benegal V, Rajkumar RP, Muralidharan K. Does areca nut use lead to dependence? Drug Alcohol Depend. 2008;97:114–21. - PubMed
-
- Winstock A. Areca nut-abuse liability, dependence and public health. Addict Biol. 2002;7:133–8. - PubMed
-
- Croucher R, Islam S. Socio-economic aspects of areca nut use. Addict Biol. 2002;7:139–46. - PubMed